for pain relief the recommended initial scheme for injections of 1 mg IV or 2 mg intramuscularly every 3-4 hours as needed. Such dosage scheme is likely to be effective for most patients. Dianabol for injection should be based on the observations relating to the expected action of side effects. The initial dose in elderly patients and in patients with impaired liver and kidney functions should generally be half the recommended adult . Repeated doses of such patients should be determined by individual patient’s reaction, typically the interval between injections is not less than 6 hours.
The usual dose, assignable before surgery is 2 mg intramuscularly 60-90 minutes prior to surgery or 2 mg IV immediately prior to anesthesia induction phase. This dosage corresponds approximately in its sedative effect of morphine 10 mg or 80 mg of meperidine. Such single preoperative dose should be individualized depending on the age, body weight, physical status of the disease, the use of other drugs and the type of anesthesia and surgery character.
During the maintenance phase during balanced anesthesia conventional incremental doses stadol injection are 0, 5-1,0 mg intravenously. Additional doses may be higher, up to 0.06 mg / kg (4 mg / 70 kg), depending on the previously used sedatives, hypnotics and analgesics. The dianabolL injection may vary; but only rarely required a dose of less than 4 mg or 12.5 mg (approximately 0,06-0,18 mg / kg). Like other opioid drugs of this class, for injection may be insufficient to complete analgesia during surgery for all patients and for all diseases. The absence of a fully successful analgesic effect during balanced anesthesia is usually manifested as an increase in the overall sympathetic tone.
Accordingly, if the blood pressure and heart rate continue to grow, you should consider adding a powerful inhalation narcotic drug or any drug is administered intravenously.
At birth the recommended initial injection of 1 or 2 mg IM or IV lying-in women with term pregnancy less than 37 weeks, with no evidence of fetal pathology. STADOL dose injection at birth should be adjusted depending on the initial reaction of mothers, and should take into account any analgesic and sedative drugs are used simultaneously , and the expected delivery date. The drug should not be administered more frequently than once every 4 hours or less than 4 hours prior to the expected delivery date.
As the use of dianabol does not require injection, your doctor may start treatment with a low dose and repeated administration of the drug if necessary. Usual recommended starting dose for intranasal administration is 1 mg (one dose aerosol each nostril). If a satisfactory analgesic effect is not obtained within 60-90 minutes, you can assign an additional dose of 1 mg. Said dosage scheme may be used at intervals of 3-4 hours as needed. For severe pain relief can be assigned an initial dose of 2 mg (one dose spray in each nostril), provided that the patients can remain in a supine position on the appearance of the case drowsiness or dizziness. Such patients should not be prescribed the drug for an additional 3-4 hours. The incidence of side effects when using higher initial dose of 2 mg. The starting stadol use in elderly patients and patients with impaired renal or hepatic function should be performed at a dose of 1 mg followed by administration of another dose of 1 mg via 90-120 minutes. Introduction of repeated doses of such patients should be determined by the patient’s reaction and not performed at fixed time intervals. Usually the drug between doses must be at least 6 hours.
Indications for use:
Injection is also indicated for sedation, as an additional drug in anesthesia and balanced to relieve pain during childbirth.
Patients with drug-dependent
butorphanol in relation to its antagonist properties with regard to opioids is not recommended in patients with drug dependence. In such patients, opioids should be canceled sufficiently in advance before the start of treatment butorphanol. For patients chronically taking opioids, the use of butorphanol led to the emergence of withdrawal symptoms such as anxiety, agitation, mood changes, hallucinations, dysphoria, weakness and diarrhea. Due to the difficulty in evaluating tolerance to opioids in patients who have recently received repeated doses of narcotic analgesics, caution should be exercised when administered to such patients butorphanol.
Information for patients
1. Drowsiness and dizziness associated with butorphanol, may violate the mental and physical abilities required for the performance of potentially dangerous tasks (eg, driving vehicles, working on mechanisms, etc.).
2. When using butorphanol should not take alcohol. The use of butorphanol concurrently with drugs that affect the central nervous system (eg, alcohol, barbiturates, tranquilizers, antihistamines) may lead to increased inhibitory effect on the central nervous system, which manifests itself in drowsiness, dizziness and infringement of intellectual functions.
3. Patients should be instructed on the proper use dianabol.